Minor Papillotomy for Treatment of Idiopathic Acute Pancreatitis With Pancreas Divisum
JAMA · 24.02.2026 · 335 (8) · 682
DOI: 10.1001/jama.2025.23988 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA, erschienen am 24.02.2026. Verfasst von Gregory A Coté und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Oregon Health & Science University, Portland. Hauptthemen laut MEDLINE: Cholangiopancreatography, Endoscopic Retrograde, Pancreas, Pancreas Divisum, Pancreatitis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Importance Pancreas divisum is implicated as an obstructive cause for acute pancreatitis. Observational data suggest endoscopic retrograde cholangiopancreatography (ERCP) with minor papillotomy reduces the risk of pancreatitis episodes. Even though this endoscopic procedure is widely used in practice, clinical trials are lacking.
Objective
To determine whether ERCP with minor papillotomy reduces the risk of acute pancreatitis among adults with unexplained acute recurrent pancreatitis and pancreas divisum. Design, Setting, and Participants This multicenter, sham-controlled, double-blind randomized clinical trial enrolled adults with 2 or more episodes of acute pancreatitis and pancreas divisum. Adults with other etiologies for acute pancreatitis or concomitant chronic calcific pancreatitis were excluded. The trial was conducted between September 1, 2018, and August 30, 2024, at 21 referral centers in the US and Canada. Last follow-up occurred on February 15, 2025.
Intervention
Participants were randomized in a 1:1 ratio to ERCP with minor papillotomy or sham ERCP. Main Outcomes and Measures The primary outcome was development of acute pancreatitis more than 30 days after randomization as a time-to-event outcome. The secondary outcomes included acute pancreatitis episode frequency and development of chronic calcific pancreatitis, diabetes, and exocrine pancreatic dysfunction.
Results
A total of 148 participants were randomized (mean age, 54 [SD, 19.5] years; 68.2% female; 95.3% non-Hispanic or Latino and 87.2% White; mean lifetime acute pancreatitis episodes, 3 [SD, 2]; mean duct diameter, 2.2 [SD, 1.3] mm) and followed up for a median of 34 months (IQR, 21.7-45.7 months). Of the 75 participants in the ERCP with minor papillotomy group, 26 (34.7%) developed acute pancreatitis compared with 32 of 73 participants (43.8%) in the sham ERCP group (adjusted hazard ratio, 0.83 [95% CI, 0.49 to 1.41]). The incidence rate ratio for acute recurrent pancreatitis episode frequency was 0.25 (95% CI, 0.18 to 0.34) in the ERCP with minor papillotomy group vs 0.30 (95% CI, 0.23 to 0.41) in the sham ERCP group. There were no between-group differences in frequency and incidence of chronic calcific pancreatitis (4.0% in the ERCP with minor papillotomy group vs 2.7% in the sham ERCP group; risk difference [RD], 0.01 [95% CI, −0.05 to 0.07]), diabetes (15.8% vs 12.8%, respectively; RD, 0.03 [95% CI, −0.13 to 0.19]), and exocrine pancreatic dysfunction (7.7% vs 17.2%; RD, −0.10 [95% CI, −0.27 to 0.08]). The adverse event of acute pancreatitis within 30 days of randomization occurred more frequently in the ERCP with minor papillotomy group (14.7%) vs the sham ERCP group (8.2%) (RD, 0.06 [95% CI, −0.04 to 0.17]). Conclusions and Relevance Among patients with unexplained acute recurrent pancreatitis and pancreas divisum, ERCP with minor papillotomy does not reduce the risk of another episode of acute pancreatitis or related sequelae. Trial Registration ClinicalTrials.gov Identifier: NCT03609944
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Oregon Health & Science University, Portland.
- Department of Public Health, Medical University of South Carolina, Charleston.
- Department of Medicine, School of Medicine, Indiana University, Indianapolis.
- Department of Medicine, University of Manitoba, Winnipeg, Canada.
- Department of Medicine, University of Virginia, Charlottesville.
- Department of Medicine, School of Medicine, Ohio State University, Columbus.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Coté, G. A., Durkalski-Mauldin, V., Fogel, E. L., Moffatt, D. C., Wang, A. Y., Lara, L. F., Tarnasky, P. R., Buxbaum, J. L., Dai, S. C., Jonnalagadda, S., Willingham, F. F., Ross, A., Keswani, R. N., Inamdar, S., Kothari, T. H., Gardner, T. B., Jamidar, P. A., Gaddam, S., Pleskow, D. K., …, & SHARP Consortium (2026). Minor Papillotomy for Treatment of Idiopathic Acute Pancreatitis With Pancreas Divisum. JAMA, 335(8), 682. https://doi.org/10.1001/jama.2025.23988
Vancouver
Coté GA, Durkalski-Mauldin V, Fogel EL, Moffatt DC, Wang AY, Lara LF, et al. Minor Papillotomy for Treatment of Idiopathic Acute Pancreatitis With Pancreas Divisum. JAMA. 2026;335(8):682. doi:10.1001/jama.2025.23988
BibTeX
@article{Cot2026,
author = {Coté, Gregory A and Durkalski-Mauldin, Valerie and Fogel, Evan L and Moffatt, Dana C and Wang, Andrew Y and Lara, Luis F and Tarnasky, Paul R and Buxbaum, James L and Dai, Sun-Chuan and Jonnalagadda, Sreeni and Willingham, Field F and Ross, Andrew and Keswani, Rajesh N and Inamdar, Sumant and Kothari, Truptesh H and Gardner, Timothy B and Jamidar, Priya A and Gaddam, Srinivas and Pleskow, Douglas K and Easler, Jeffrey J and Elmunzer, B Joseph and Coneys, John Gerard and Mallery, J Shawn and Strand, Daniel S and Papachristou, Georgios I and Slivka, Adam and Kedia, Prashant and Sahakian, Ara B and Kouanda, Abdul and Phan, Anh and Williams, April and Andersen, Dana K and Serrano, Jose and Yadav, Dhiraj and SHARP Consortium, SHARP Consortium},
title = {Minor Papillotomy for Treatment of Idiopathic Acute Pancreatitis With Pancreas Divisum},
journal = {JAMA},
year = {2026},
volume = {335},
number = {8},
pages = {682},
doi = {10.1001/jama.2025.23988}
}
EUVIMED